within Pharmacolibrary.Drugs.ATC.P;

model P01BE01_1
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 4.3333333333333334e-05,
    adminDuration  = 600,
    adminMass      = 120 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.0034,
    k12             = 5.3,
    k21             = 5.3
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>P01BE01_1</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Artemisinin is a sesquiterpene lactone isolated from the plant Artemisia annua, used primarily as an antimalarial agent. It is effective against Plasmodium falciparum malaria and is used in combination therapies for treatment. Artemisinin and its derivatives are widely used and recommended by the World Health Organization (WHO) for malaria treatment.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after intravenous bolus administration.</p><h4>References</h4><ol><li><p>Ibrahim, N, et al., &amp; Nepveu, F (2015). Artemisinin nanoformulation suitable for intravenous injection: Preparation, characterization and antimalarial activities. <i>International journal of pharmaceutics</i> 495(2) 671–679. DOI:<a href=\"https://doi.org/10.1016/j.ijpharm.2015.09.020\">10.1016/j.ijpharm.2015.09.020</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26383839/\">https://pubmed.ncbi.nlm.nih.gov/26383839</a></p></li><li><p> (2020). IV artesunate for severe malaria. <i>The Medical letter on drugs and therapeutics</i> 62(1604) 121–124. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32960866/\">https://pubmed.ncbi.nlm.nih.gov/32960866</a></p></li><li><p>Chai, L, et al., &amp; Zhang, S (2021). Auto-Induction of Intestinal First-Pass Effect Related Time-Dependent Pharmacokinetics of Artemisinin Rather than Dihydroartemisinin. <i>Journal of pharmaceutical sciences</i> 110(1) 458–466. DOI:<a href=\"https://doi.org/10.1016/j.xphs.2020.09.023\">10.1016/j.xphs.2020.09.023</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32976901/\">https://pubmed.ncbi.nlm.nih.gov/32976901</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end P01BE01_1;
